Consistent with the results from the datasets, the expression levels of ADH1C, SLC26A2, and NANS were substantially decreased in tumor tissues compared with those in the corresponding adjacent tissues (P<0.01; Figure 7F). This evidence concerns the gene SLC26A2 and neoplasm.